{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:47:32Z","timestamp":1768294052883,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yunnan Provincial Cardiovascular Disease Clinical Medical Center Project","award":["FZX2019-06-01"],"award-info":[{"award-number":["FZX2019-06-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Functional mitral regurgitation (FMR) worsens the prognosis of patients with heart failure with preserved ejection fraction (HFpEF). While concomitant mitral valve surgery (MVS) is recommended for severe FMR during aortic valve replacement (AVR), the optimal treatment of moderate FMR, especially in those with HFpEF, remains unclear. This study aimed to evaluate the effect of MVS in patients with moderate FMR and HFpEF undergoing AVR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 212 consecutive patients (AVR: 34.0%, AVR-MVS: 66.0%) during 2010 and 2019 were enrolled. Survival outcomes were compared. Inverse probability treatment weighting (IPTW) was used to balance the baseline characteristics. Kaplan-Meier curve and log-rank test were\u00a0applied to compare the survival outcomes.\u00a0The primary endpoint was the\u00a0overall mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age was 58.9 <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\pm$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mo>\u00b1<\/mml:mo>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula> 11.9\u00a0years, and 27.8% of them were female. During a median follow-up of 16.4\u00a0months, AVR-MVS did not reduce the risk of mid-term MACCE (hazard ratio [HR]: 1.53, 95% confidence interval [CI]: 0.57\u20134.17, P<jats:sub>log-rank<\/jats:sub>\u2009=\u20090.396), while it showed a tendency toward higher MACCE risk in the IPTW analysis (HR:\u00a02.62, 95% CI:\u00a00.84\u20138.16, P<jats:sub>log-rank<\/jats:sub>\u2009=\u20090.096). In addition, AVR-MVS increased the risk of mortality as compared to isolated AVR (0 vs. 10%, P<jats:sub>log-rank<\/jats:sub>\u2009=\u20090.016), which was sustained in the IPTW analysis\u00a0 (0 vs. 9.9%, P<jats:sub>log-rank<\/jats:sub>&lt;0.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In patients with moderate FMR and HFpEF, isolated AVR might be more reasonable than AVR-MVS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-023-02197-2","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:05:49Z","timestamp":1680714349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of concomitant mitral valve surgery on the clinical outcomes of patients with moderate functional mitral regurgitation and HFpEF undergoing aortic valve replacement: a cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Xieraili","family":"Tiemuerniyazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangwu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"2197_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124:1598\u2013617.","journal-title":"Circ Res"},{"key":"2197_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/eurjhf\/hfq014","volume":"12","author":"F Bursi","year":"2010","unstructured":"Bursi F, Barbieri A, Grigioni F, Reggianini L, et al. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail. 2010;12:382\u20138.","journal-title":"Eur J Heart Fail"},{"key":"2197_CR3","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ejhf.562","volume":"18","author":"K Kajimoto","year":"2016","unstructured":"Kajimoto K, Sato N, Takano T, et al. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction. Eur J Heart Fail. 2016;18:1051\u20139.","journal-title":"Eur J Heart Fail"},{"key":"2197_CR4","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.3390\/jcm9113432","volume":"9","author":"Z Balogh","year":"2020","unstructured":"Balogh Z, Mizukami T, Bartunek J, et al. Mitral valve repair of atrial functional mitral regurgitation in heart failure with preserved ejection fraction. J Clin Med. 2020;9:3432.","journal-title":"J Clin Med"},{"key":"2197_CR5","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379:2307\u201318.","journal-title":"N Engl J Med"},{"key":"2197_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70:252\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"2197_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/icvts\/ivw212","volume":"23","author":"AR Kowalowka","year":"2016","unstructured":"Kowalowka AR, Onyszczuk M, Wanha W, et al. Do we have to operate on moderate functional mitral regurgitation during aortic valve replacement for aortic stenosis? Interact Cardiovasc Thorac Surg. 2016;23:806\u20139.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2197_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1540-8191.2009.00965.x","volume":"25","author":"AA Alghamdi","year":"2010","unstructured":"Alghamdi AA, Elmistekawy EM, Singh SK, et al. Is concomitant surgery for moderate functional mitral regurgitation indicated during aortic valve replacement for aortic stenosis? A systematic review and evidence-based recommendations. J Card Surg. 2010;25:182\u20137.","journal-title":"J Card Surg"},{"key":"2197_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmj.2.5402.177","volume":"2","author":"PP Rickham","year":"1964","unstructured":"Rickham PP. Human experimentation. Code of ethics of the world medical association. Declaration of helsinki. Br Med J. 1964;2:177.","journal-title":"Br Med J"},{"key":"2197_CR10","first-page":"101161CIR000000","volume":"2022","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;2022:101161CIR0000000000001063.","journal-title":"Circulation"},{"key":"2197_CR11","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179\u201384.","journal-title":"Nephron Clin Pract"},{"key":"2197_CR12","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehs339","volume":"34","author":"C Berry","year":"2013","unstructured":"Berry C, Lloyd SM, Wang Y, et al. The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. Eur Heart J. 2013;34:1538\u201347.","journal-title":"Eur Heart J"},{"key":"2197_CR13","doi-asserted-by":"publisher","first-page":"e001701","DOI":"10.1136\/openhrt-2021-001701","volume":"8","author":"FH Verbrugge","year":"2021","unstructured":"Verbrugge FH, Reddy YNV, Eleid MF, et al. Mild aortic valve disease and the diastolic pressure-volume relationship in heart failure with preserved ejection fraction. Open Heart. 2021;8:e001701.","journal-title":"Open Heart"},{"key":"2197_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12983","author":"T Abdurashidova","year":"2020","unstructured":"Abdurashidova T, Monney P, Tzimas G, et al. Non-severe aortic regurgitation increases short-term mortality in acute heart failure with preserved ejection fraction. ESC Heart Fail. 2020. https:\/\/doi.org\/10.1002\/ehf2.12983.","journal-title":"ESC Heart Fail"},{"key":"2197_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jjcc.2018.12.017","volume":"73","author":"H Namisaki","year":"2019","unstructured":"Namisaki H, Nagata Y, Seo Y, et al. Symptomatic paradoxical low gradient severe aortic stenosis: a possible link to heart failure with preserved ejection fraction. J Cardiol. 2019;73:536\u201343.","journal-title":"J Cardiol"},{"key":"2197_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ejhf.1699","volume":"22","author":"M Tamargo","year":"2020","unstructured":"Tamargo M, Obokata M, Reddy YNV, et al. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22:489\u201398.","journal-title":"Eur J Heart Fail"},{"key":"2197_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.cardfail.2011.05.013","volume":"17","author":"S Marechaux","year":"2011","unstructured":"Marechaux S, Neicu DV, Braun S, et al. Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction. J Cardiac Fail. 2011;17:806\u201312.","journal-title":"J Cardiac Fail"},{"key":"2197_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0735-1097(96)00436-6","volume":"29","author":"M Enriquez-Sarano","year":"1997","unstructured":"Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29:153\u20139.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-023-02197-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-023-02197-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:08:50Z","timestamp":1680714530000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-023-02197-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1186\/s13019-023-02197-2","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"20 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation conforms with the principles outlined in <i>the Declaration of Helsinki<\/i>. The Institutional Review Board at our institute approved the use of clinical data for this study (NO.: 2021-1585).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent was waived by the Institutional Review Board at our institute considering the retrospective design of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}